Soft tissue sarcoma, version 2.2014: Featured updates to the NCCN guidelines

JNCCN Journal of the National Comprehensive Cancer Network

Volumn 12, Issue 4, 2014, Pages 473-483

  Von Mehren, Margaret ^a   Lor Randall, R ^b   Benjamin, Robert S ^c   Boles, Sarah ^d   Bui, Marilyn M ^e   Casper, Ephraim S ^f   Conrad III, Ernest U ^g   DeLaney, Thomas F ^h   Ganjoo, Kristen N ⁱ   George, Suzanne ^j   Gonzalez, Ricardo J ^e   Heslin, Martin J ^k   Kane III, John M ^l   Mayerson, Joel ^m   McGarry, Sean V ⁿ   Meyer, Christian ^o   O'Donnell, Richard J ^p   Pappo, Alberto S ^q   Paz, I Benjamin ^r   Pfeifer, John D ^s   Riedel, Richard F ^t   Schuetze, Scott ^u   Schupak, Karen D ^f   Schwartz, Herbert S ^v   Van Tine, Brian A ^s   Wayne, Jeffrey D ^w   Bergman, Mary Anne ^x   Sundar, Hema ^x   more..

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^f MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^g SEATTLE CANCER CARE ALLIANCE   (United States)

^h MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

ⁱ STANFORD CANCER INSTITUTE   (United States)

^j DANA FARBER BRIGHAM AND WOMEN S CANCER CENTER   (United States)

^k UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^l ROSWELL PARK CANCER INSTITUTE   (United States)

^m OHIO STATE UNIVERSITY   (United States)

ⁿ NEBRASKA MEDICAL CENTER   (United States)

^o JOHNS HOPKINS UNIVERSITY   (United States)

^p UNIVERSITY OF CALIFORNIA   (United States)

^q UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^r CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^s BARNES JEWISH HOSPITAL   (United States)

^t DUKE CANCER INSTITUTE   (United States)

^u UNIVERSITY OF MICHIGAN COMPREHENSIVE CANCER CENTER   (United States)

^v VANDERBILT INGRAM CANCER CENTER   (United States)

^w NORTHWESTERN UNIVERSITY   (United States)

^x National Comprehensive Cancer Network in Plymouth Meeting   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACCREDITATION; CANCER GENETICS; CANCER SUSCEPTIBILITY; CONTINUING EDUCATION; EXTERNAL BEAM RADIOTHERAPY; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; GENETIC COUNSELING; GENETIC SCREENING; GERMLINE MUTATION; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCAL RECURRENCE FREE SURVIVAL; PRACTICE GUIDELINE; PROTON THERAPY; RADIATION DOSE; REVIEW; SOFT TISSUE SARCOMA; TOMOTHERAPY; GENETICS; SARCOMA;

GENETIC TESTING; HUMANS; SARCOMA;

EID: 84900391966     PISSN: 15401405     EISSN: 15401413     Source Type: Journal    
DOI: 10.6004/jnccn.2014.0053     Document Type: Review

References (42)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
2. Li FP, Fraumeni JF Jr, Mulvihill JJ, et al. A cancer family syndrome in twenty-four kindreds. Cancer Res 1988;48:5358-5362.
3. Zahm S, Fraumeni JJ. The epidemiology of soft tissue sarcoma. Semin Oncol 1997;24:504-514. (Pubitemid 27449586)
4. Galiatsatos P, Foulkes WD. Familial adenomatous polyposis. Am J Gastroenterol 2006;101:385-398. (Pubitemid 43381685)
5. Kleinerman RA, Tucker MA, Abramson DH, et al. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma. J Natl Cancer Inst 2007;99:24-31.
6. Half E, Bercovich D, Rozen P. Familial adenomatous polyposis. Orphanet J Rare Dis 2009;4:22.
7. Postow MA, Robson ME. Inherited gastrointestinal stromal tumor syndromes: mutations, clinical features, and therapeutic implications. Clin Sarcoma Res 2012;2:16.
8. Malkin D, Li FP, Strong LC, et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990;250:1233-1238. (Pubitemid 120031831)
9. Nichols KE, Malkin D, Garber JE, et al. Germ-line p53 mutations predispose to a wide spectrum of early-onset cancers. Cancer Epidemiol Biomarkers Prev 2001;10:83-87. (Pubitemid 32172424)
10. Ognjanovic S, Olivier M, Bergemann TL, Hainaut P. Sarcomas in TP53 germline mutation carriers. Cancer 2012;118:1387-1396.
11. Kleihues P, Schauble B, zur Hausen A, et al. Tumors associated with p53 germline mutations: a synopsis of 91 families. Am J Pathol 1997;150:1-13. (Pubitemid 27027090)
12. Olivier M, Goldgar DE, Sodha N, et al. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Cancer Res 2003;63:6643-6650. (Pubitemid 37322942)
13. Mitchell G, Ballinger ML, Wong S, et al. High frequency of germline TP53 mutations in a prospective adult-onset sarcoma cohort. PLoS One 2013;8:e69026.
14. Bisgaard ML, Bulow S. Familial adenomatous polyposis (FAP): genotype correlation to FAP phenotype with osteomas and sebaceous cysts. Am J Med Genet A 2006;140:200-204. (Pubitemid 43190928)
15. Gurbuz AK, Giardiello FM, Petersen GM, et al. Desmoid tumours in familial adenomatous polyposis. Gut 1994;35:377-381. (Pubitemid 24092910)
16. Fallen T, Wilson M, Morlan B, Lindor NM. Desmoid tumors - a characterization of patients seen at Mayo Clinic 1976-1999. Fam Cancer 2006;5:191-194. (Pubitemid 43824476)
17. Nieuwenhuis MH, Casparie M, Mathus-Vliegen LM, et al. A nation-wide study comparing sporadic and familial adenomatous polyposis-related desmoid-type fibromatoses. Int J Cancer 2011;129:256-261.
18. Nieuwenhuis MH, Lefevre JH, Bulow S, et al. Family history, surgery, and APC mutation are risk factors for desmoid tumors in familial adenomatous polyposis: an international cohort study. Dis Colon Rectum 2011;54:1229-1234.
19. Carney JA, Stratakis CA. Familial paraganglioma and gastric stromal sarcoma: a new syndrome distinct from the Carney triad. Am J Med Genet 2002;108:132-139.
20. Pasini B, McWhinney SR, Bei T, et al. Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD. Eur J Hum Genet 2008;16:79-88. (Pubitemid 350284184)
21. Gill AJ, Chou A, Vilain R, et al. Immunohistochemistry for SDHB divides gastrointestinal stromal tumors (GISTs) into 2 distinct types. Am J Surg Pathol 2010;34:636-644.
22. Gaal J, Stratakis CA, Carney JA, et al. SDHB immunohistochemistry: a useful tool in the diagnosis of Carney-Stratakis and Carney triad gastrointestinal stromal tumors. Mod Pathol 2011;24:147-151.
23. Raut CP, Pisters PW. Retroperitoneal sarcomas: combined-modality treatment approaches. J Surg Oncol 2006;94:81-87. (Pubitemid 43967728)
24. Musat E, Kantor G, Caron J, et al. Comparison of intensity-modulated postoperative radiotherapy with conventional postoperative conformal radiotherapy for retroperitoneal sarcoma. Cancer Radiother 2004;8:255-261. (Pubitemid 39278303)
25. Yoon SS, Chen YL, Kirsch DG, et al. Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas. Ann Surg Oncol 2010;17:1515-1529.
26. Kim B, Chen YL, Kirsch DG, et al. An effective preoperative three-dimensional radiotherapy target volume for extremity soft tissue sarcoma and the effect of margin width on local control. Int J Radiat Oncol Biol Phys 2010;77:843-850.
27. Swanson EL, Indelicato DJ, Louis D, et al. Comparison of three-dimensional (3D) conformal proton radiotherapy (RT), 3D conformal photon RT, and intensity-modulated RT for retroperitoneal and intra-abdominal sarcomas. Int J Radiat Oncol Biol Phys 2012;83:1549-1557.
28. Zlotecki RA, Katz TS, Morris CG, et al. Adjuvant radiation therapy for resectable retroperitoneal soft tissue sarcoma: the University of Florida experience. Am J Clin Oncol 2005;28:310-316. (Pubitemid 40800485)
29. Pawlik TM, Pisters PWT, Mikula L, et al. Long-term results of two prospective trials of preoperative external beam radiotherapy for localized intermediate- or high-grade retroperitoneal soft tissue sarcoma. Ann Surg Oncol 2006;13:508-517.
30. Tzeng CW, Fiveash JB, Popple RA, et al. Preoperative radiation therapy with selective dose escalation to the margin at risk for retroperitoneal sarcoma. Cancer 2006;107:371-379. (Pubitemid 44036567)
31. Catton CN, O'Sullivan B, Kotwall C, et al. Outcome and prognosis in retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 1994;29:1005-1010. (Pubitemid 24278967)
32. Heslin MJ, Lewis JJ, Nadler E, et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma: implications for management. J Clin Oncol 1997;15:2832-2839. (Pubitemid 27330010)
33. Jones JJ, Catton CN, O'Sullivan B, et al. Initial results of a trial of preoperative external-beam radiation therapy and postoperative brachytherapy for retroperitoneal sarcoma. Ann Surg Oncol 2002;9:346-354. (Pubitemid 34496722)
34. Le Péchoux C, Musat E, Baey C, et al. Should adjuvant radiotherapy be administered in addition to front-line aggressive surgery (FAS) in patients with primary retroperitoneal sarcoma? Ann Oncol 2013;24:832-837.
35. Sindelar WF, Kinsella TJ, Chen PW, et al. Intraoperative radiotherapy in retroperitoneal sarcomas. Final results of a prospective, randomized, clinical trial. Arch Surg 1993;128:402-410. (Pubitemid 23115380)
36. Alektiar KM, Hu K, Anderson L, et al. High-dose-rate intraoperative radiation therapy (HDR-IORT) for retroperitoneal sarcomas. Int J Radiat Oncol Biol Phys 2000;47:157-163. (Pubitemid 30179689)
37. Gieschen HL, Spiro IJ, Suit HD, et al. Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma. Int J Radiat Oncol Biol Phys 2001;50:127-131.
38. Petersen IA, Haddock MG, Donohue JH, et al. Use of intraoperative electron beam radiotherapy in the management of retroperitoneal soft tissue sarcomas. Int J Radiat Oncol Biol Phys 2002;52:469-475. (Pubitemid 34170851)
39. Bobin JY, Al-Lawati T, Granero LE, et al. Surgical management of retroperitoneal sarcomas associated with external and intraoperative electron beam radiotherapy. Eur J Surg Oncol 2003;29:676-681. (Pubitemid 37236290)
40. Pisters PW, Ballo MT, Fenstermacher MJ, et al. Phase I trial of preoperative concurrent doxorubicin and radiation therapy, surgical resection, and intraoperative electron-beam radiation therapy for patients with localized retroperitoneal sarcoma. J Clin Oncol 2003;21:3092-3097. (Pubitemid 46606290)
41. Krempien R, Roeder F, Oertel S, et al. Intraoperative electron-beam therapy for primary and recurrent retroperitoneal soft-tissue sarcoma. Int J Radiat Oncol Biol Phys 2006;65:773-779. (Pubitemid 43795839)
42. Yoon SS, Chen YL, Kambadakone A, et al. Surgical placement of biologic mesh spacers prior to external beam radiation for retroperitoneal and pelvic tumors. Pract Radiat Oncol 2013;3:199-208.